Stocktoria
HALOZYME THERAPEUTICS, INC. HALO
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2003-01-30
HALOZYME THERAPEUTICS, INC. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 17,619,937 | $922.6M |
| D. E. Shaw & Co., Inc. | 1,899,408 | $122.8M |
| TWO SIGMA INVESTMENTS, LP | 1,584,961 | $102.4M |
| AQR CAPITAL MANAGEMENT LLC | 1,016,429 | $64.8M |
| RENAISSANCE TECHNOLOGIES LLC | 731,811 | $47.3M |
| Bridgewater Associates, LP | 511,429 | $33.1M |
| MILLENNIUM MANAGEMENT LLC | 471,284 | $30.5M |
| CITADEL ADVISORS LLC | 281,851 | $18.2M |
Source: SEC EDGAR filings · CIK 0001159036 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.